As reported previously, UBS upgraded Phase Forward to Buy from Neutral. The firm believes Phase Forward is poised for EPS acceleration and margin expansion now that dilutive acquisitions have been completed. Target to $20 from $14. :theflyonthewall.com
News For PFWD From The Last 14 Days
Check below for free stories on PFWD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
